- Home
- TVRD vs GROW Comparison
TVRD vs GROW Comparison
Compare TVRD & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVRD | GROW |
|---|---|---|
| Founded | 2017 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 31.3M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TVRD | GROW |
|---|---|---|
| Price | $3.64 | $3.22 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $51.67 | N/A |
| AVG Volume (30 Days) | 51.6K | ★ 107.5K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $23,850,609.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $65.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.50 | $2.05 |
| 52 Week High | $43.65 | $3.65 |
Technical Indicators
Market Signals| Indicator | TVRD | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 59.76 |
| Support Level | $3.51 | $2.88 |
| Resistance Level | $3.89 | $3.32 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 23.40 | 55.66 |
Price Performance
Historical ComparisonAbout TVRD Tvardi Therapeutics Inc.
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.